NORTHWOOD, OHIO – June 1, 2012 – NAMSA, a world leading contract research organization for medical devices, announced that its French business unit, Biomatech, will now conduct business under the NAMSA brand name.
NAMSA completed the acquisition of Biomatech in 2005. Located near Lyon in Chasse-sur-Rhone, Biomatech was founded by Dr. Rosy Eloy in 1986 and provides non-clinical testing services comparable to those offered by NAMSA’s North American laboratory operations. “Given the similarities among each of the company’s offering, business philosophy and clients, operating under a single brand makes sense from both a cultural and market perspective” stated Terry Langenderfer, Director of Global Marketing.
NAMSA also recently announced the opening of its office near Frankfurt which provides clinical research and consulting services. “A unified, global brand is a central element of our growth strategy as NAMSA continues to expand geographically,” added Langenderfer.
NAMSA (www.namsa.com) is a global medical device research organization providing a comprehensive range of services to prove efficacy, non-clinical and clinical safety of medical devices, IVDs and combination products. For more than 45 years, NAMSA clients have utilized its testing and consulting services to bring safe and effective therapies to market.